376 related articles for article (PubMed ID: 29383752)
1. Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6.
Jiang X; Huang Y; Liang X; Jiang F; He Y; Li T; Xu G; Zhao H; Yang W; Jiang G; Su Z; Jiang L; Liu L
Prostate; 2018 May; 78(6):426-434. PubMed ID: 29383752
[TBL] [Abstract][Full Text] [Related]
2. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
[TBL] [Abstract][Full Text] [Related]
3. Potassium Bisperoxo(1,10-phenanthroline)oxovanadate (bpV(phen)) Induces Apoptosis and Pyroptosis and Disrupts the P62-HDAC6 Protein Interaction to Suppress the Acetylated Microtubule-dependent Degradation of Autophagosomes.
Chen Q; Yue F; Li W; Zou J; Xu T; Huang C; Zhang Y; Song K; Huang G; Xu G; Huang H; Li J; Liu L
J Biol Chem; 2015 Oct; 290(43):26051-8. PubMed ID: 26363065
[TBL] [Abstract][Full Text] [Related]
4. SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity.
Yan J; Seibenhener ML; Calderilla-Barbosa L; Diaz-Meco MT; Moscat J; Jiang J; Wooten MW; Wooten MC
PLoS One; 2013; 8(9):e76016. PubMed ID: 24086678
[TBL] [Abstract][Full Text] [Related]
5. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin).
Singh K; Sharma A; Mir MC; Drazba JA; Heston WD; Magi-Galluzzi C; Hansel D; Rubin BP; Klein EA; Almasan A
Mol Cancer; 2014 Mar; 13():70. PubMed ID: 24655592
[TBL] [Abstract][Full Text] [Related]
6. SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial-mesenchymal transition and mitochondrial function maintenance.
Chen J; Gao Z; Li X; Shi Y; Tang Z; Liu W; Zhang X; Huang A; Luo X; Gao Q; Ding G; Song K; Zhou J; Fan J; Fu X; Ding Z
Cancer Med; 2023 Jan; 12(1):459-471. PubMed ID: 35676831
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
[TBL] [Abstract][Full Text] [Related]
9. p62/SQSTM1 is required for cell survival of apoptosis-resistant bone metastatic prostate cancer cell lines.
Chang MA; Morgado M; Warren CR; Hinton CV; Farach-Carson MC; Delk NA
Prostate; 2014 Feb; 74(2):149-63. PubMed ID: 24122957
[TBL] [Abstract][Full Text] [Related]
10. Requirement for p62 acetylation in the aggregation of ubiquitylated proteins under nutrient stress.
You Z; Jiang WX; Qin LY; Gong Z; Wan W; Li J; Wang Y; Zhang H; Peng C; Zhou T; Tang C; Liu W
Nat Commun; 2019 Dec; 10(1):5792. PubMed ID: 31857589
[TBL] [Abstract][Full Text] [Related]
11. p62 promotes proliferation, apoptosis‑resistance and invasion of prostate cancer cells through the Keap1/Nrf2/ARE axis.
Jiang G; Liang X; Huang Y; Lan Z; Zhang Z; Su Z; Fang Z; Lai Y; Yao W; Liu T; Hu L; Wang F; Huang H; Liu L; Jiang X
Oncol Rep; 2020 May; 43(5):1547-1557. PubMed ID: 32323805
[TBL] [Abstract][Full Text] [Related]
12. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
13. Expression and role of autophagy-associated p62 (SQSTM1) in multidrug resistant ovarian cancer.
Wang J; Garbutt C; Ma H; Gao P; Hornicek FJ; Kan Q; Shi H; Duan Z
Gynecol Oncol; 2018 Jul; 150(1):143-150. PubMed ID: 29699801
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
15. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
[TBL] [Abstract][Full Text] [Related]
16. Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue.
Kitamura H; Torigoe T; Asanuma H; Hisasue SI; Suzuki K; Tsukamoto T; Satoh M; Sato N
Histopathology; 2006 Jan; 48(2):157-61. PubMed ID: 16405664
[TBL] [Abstract][Full Text] [Related]
17. p62/Sequestosome 1 regulates transforming growth factor beta signaling and epithelial to mesenchymal transition in A549 cells.
Trelford CB; Ng E; Campbell CI; Di Guglielmo GM
Cell Signal; 2021 Sep; 85():110040. PubMed ID: 34000385
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
[TBL] [Abstract][Full Text] [Related]
19. Both p62/SQSTM1-HDAC6-dependent autophagy and the aggresome pathway mediate CDK1 degradation in human breast cancer.
Galindo-Moreno M; Giráldez S; Sáez C; Japón MÁ; Tortolero M; Romero F
Sci Rep; 2017 Aug; 7(1):10078. PubMed ID: 28855742
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of LC3B and p62/SQSTM1 Expression in Gastric Adenocarcinoma.
Kim JS; Bae GE; Kim KH; Lee SI; Chung C; Lee D; Lee TH; Kwon IS; Yeo MK
Anticancer Res; 2019 Dec; 39(12):6711-6722. PubMed ID: 31810936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]